A coalition of major pharmaceutical manufacturers and an industry trade organization have dropped a lawsuit challenging a Kansas law barring them from limiting discounts to pharmacies operating under a federal drug discount program.
Abbvie Inc., Novartis, AstraZeneca and the Pharmaceutical Research and Manufacturers of America filed a legal challenge last summer to a budget proviso requiring drug manufacturers to sell outpatient drugs at a discount to safety-net providers and certain hospitals with low-income patients.
Last month, the pharmaceutical companies and trade group reached an agreement . . .
SSJ
This content is restricted to subscribers. Click here to subscribe. Already a subscriber? Click here to login.
